NCT02632890 Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries Status COMPLETED Phase N/A
NCT02629159 A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02627924 Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab Status COMPLETED Phase N/A
NCT02626026 Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT02622503 A Study on Rheumatoid Arthritis Patients Treated With Rituximab Status COMPLETED Phase N/A
NCT02616380 Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan Status COMPLETED Phase N/A
NCT02616328 A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice Status TERMINATED Phase N/A
NCT02608112 Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year Status COMPLETED Phase N/A
NCT02605642 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade Status COMPLETED Phase N/A
NCT02600468 Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg Status COMPLETED Phase N/A
NCT02600455 Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL Status COMPLETED Phase N/A
NCT02598466 Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa Status COMPLETED Phase N/A
NCT02590562 An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients. Status COMPLETED Phase N/A
NCT02585258 The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study Status COMPLETED Phase PHASE4
NCT02573012 Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants Status COMPLETED Phase PHASE4
NCT02566967 An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective Status COMPLETED Phase PHASE3